Annual Current Assets
$54.78 M
-$25.44 M-31.72%
31 December 2022
Summary:
Zynerba Pharmaceuticals annual total current assets is currently $54.78 million, with the most recent change of -$25.44 million (-31.72%) on 31 December 2022. During the last 3 years, it has fallen by -$18.59 million (-25.34%).ZYNE Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Assets
$39.30 M
-$8.28 M-17.41%
30 June 2023
Summary:
Zynerba Pharmaceuticals quarterly total current assets is currently $39.30 million, with the most recent change of -$8.28 million (-17.41%) on 30 June 2023.ZYNE Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZYNE Current Assets Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | - | - |
3 y3 years | -25.3% | -55.4% |
5 y5 years | -18.2% | -58.1% |
ZYNE Current Assets High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | ||||
5 y | 5 years | ||||
alltime | all time | -37.1% | -63.3% |
Zynerba Pharmaceuticals Current Assets History
Date | Annual | Quarterly |
---|---|---|
June 2023 | - | $39.30 M(-17.4%) |
Mar 2023 | - | $47.58 M(-13.1%) |
Dec 2022 | $745.80 K(-21.6%) | $54.78 M(-9.9%) |
Sept 2022 | - | $60.80 M(-7.4%) |
June 2022 | - | $65.67 M(-10.3%) |
Mar 2022 | - | $73.23 M(-8.7%) |
Dec 2021 | $951.60 K(+37.8%) | $80.22 M(-8.9%) |
Sept 2021 | - | $88.06 M(-8.7%) |
June 2021 | - | $96.46 M(-10.0%) |
Mar 2021 | - | $107.20 M(+46.1%) |
Dec 2020 | $690.60 K(-2.5%) | $73.37 M(-1.9%) |
Sept 2020 | - | $74.76 M(-12.4%) |
June 2020 | - | $85.34 M(+13.8%) |
Mar 2020 | - | $75.02 M(-13.8%) |
Dec 2019 | $708.60 K(+90.5%) | $87.06 M(-7.2%) |
Sept 2019 | - | $93.83 M(+0.3%) |
June 2019 | - | $93.57 M(+26.1%) |
Mar 2019 | - | $74.22 M(+10.8%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2018 | $372.00 K(-55.0%) | $66.96 M(-7.9%) |
Sept 2018 | - | $72.69 M(+48.2%) |
June 2018 | - | $49.04 M(-15.4%) |
Mar 2018 | - | $57.97 M(-15.0%) |
Dec 2017 | $826.70 K(+475.7%) | $68.23 M(-6.4%) |
Sept 2017 | - | $72.88 M(-4.7%) |
June 2017 | - | $76.46 M(-8.3%) |
Mar 2017 | - | $83.36 M(+129.0%) |
Dec 2016 | $143.60 K(-37.0%) | $36.41 M(+2.5%) |
Sept 2016 | - | $35.53 M(-0.2%) |
June 2016 | - | $35.59 M(-7.6%) |
Mar 2016 | - | $38.53 M(-11.3%) |
Dec 2015 | $227.80 K(+945.0%) | $43.42 M(-7.4%) |
Sept 2015 | - | $46.87 M(+399.9%) |
June 2015 | - | $9.37 M(-8.9%) |
Mar 2015 | - | $10.29 M(-11.2%) |
Dec 2014 | $21.80 K(-98.1%) | $11.59 M |
Dec 2013 | $1.17 M | - |
FAQ
- What is Zynerba Pharmaceuticals annual total current assets?
- What is the all time high annual current assets for Zynerba Pharmaceuticals?
- What is Zynerba Pharmaceuticals quarterly total current assets?
- What is the all time high quarterly current assets for Zynerba Pharmaceuticals?
What is Zynerba Pharmaceuticals annual total current assets?
The current annual current assets of ZYNE is $54.78 M
What is the all time high annual current assets for Zynerba Pharmaceuticals?
Zynerba Pharmaceuticals all-time high annual total current assets is $87.06 M
What is Zynerba Pharmaceuticals quarterly total current assets?
The current quarterly current assets of ZYNE is $39.30 M
What is the all time high quarterly current assets for Zynerba Pharmaceuticals?
Zynerba Pharmaceuticals all-time high quarterly total current assets is $107.20 M